We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-3.03%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$8.84B
AUM Growth
-$870M
Cap. Flow
-$334M
Cap. Flow %
-3.78%
Top 10 Hldgs %
9.41%
Holding
997
New
62
Increased
315
Reduced
362
Closed
68

Top Buys

Rank Stock Value
1
KD icon
Kyndryl
KD
+$22.1M
2
CRI icon
Carter's
CRI
+$21.6M
3
ENOV icon
Enovis
ENOV
+$19.7M
4
M icon
Macy's
M
+$18.4M
5
SPNS
Sapiens International
SPNS
+$18.3M

Top Sells

Rank Stock Value
1
VIVO
Meridian Bioscience Inc
VIVO
+$48.8M
2
SPB icon
Spectrum Brands
SPB
+$27.6M
3
HUN icon
Huntsman Corp
HUN
+$22.1M
4
EAF icon
GrafTech
EAF
+$17.5M
5
VNT icon
Vontier
VNT
+$17.5M

Sector Composition

Rank Sector Weight
1 Industrials 27.25%
2 Technology 17.95%
3 Consumer Discretionary 13.92%
4 Financials 13.49%
5 Materials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLPC icon
126
Preformed Line Products
PLPC
$1.39B
$18.3M 0.21%
257,124
+1,000
+0.4% +$70.4K
RLI icon
127
RLI Corp
RLI
$6.02B
$18.3M 0.21%
356,740
+23,740
+7% +$1.33M
WMS icon
128
Advanced Drainage Systems
WMS
$10.6B
$17.7M 0.2%
142,018
+105,166
+285% +$13.1M
AGYS icon
129
Agilysys
AGYS
$3.21B
$17.7M 0.2%
318,988
+460
+0.1% +$23.2K
BOKF icon
130
BOK Financial
BOKF
$8.58B
$17.6M 0.2%
198,374
-8
-0% -$692
KD icon
131
Kyndryl
KD
$3.09B
$17.6M 0.2%
+2,126,158
New +$22.1M
MTDR icon
132
Matador Resources
MTDR
$6.04B
$17.5M 0.2%
358,072
+61,000
+21% +$3.29M
LAZ icon
133
Lazard
LAZ
$4B
$17.4M 0.2%
547,409
-52,900
-9% -$1.9M
IRWD icon
134
Ironwood Pharmaceuticals
IRWD
$586M
$17.4M 0.2%
1,678,211
+184,574
+12% +$2.09M
CNTY icon
135
Century Casinos
CNTY
$32.9M
$17.1M 0.19%
2,614,163
+22,087
+0.9% +$170K
NVMI
136
Nova
NVMI
$11.7B
$17.1M 0.19%
200,047
-26,870
-12% -$2.64M
SPNS
137
DELISTED
Sapiens International
SPNS
$17M 0.19%
885,001
+808,966
+1,064% +$18.3M
M icon
138
Macy's
M
$6.51B
$16.9M 0.19%
1,080,000
+1,036,000
+2,355% +$18.4M
AMKR icon
139
Amkor Technology
AMKR
$10.6B
$16.8M 0.19%
985,931
-168,000
-15% -$3.23M
TRS icon
140
TriMas Corp
TRS
$1.41B
$16.8M 0.19%
670,395
-110,663
-14% -$3.05M
FHI icon
141
Federated Hermes
FHI
$4.56B
$16.7M 0.19%
505,000
-58,672
-10% -$2M
FTAI icon
142
FTAI Aviation
FTAI
$20.2B
$16.7M 0.19%
1,114,114
+249,942
+29% +$4.31M
USLM icon
143
United States Lime & Minerals
USLM
$3.24B
$16.5M 0.19%
805,480
+41,980
+5% +$893K
LASR icon
144
nLIGHT
LASR
$3.33B
$16.3M 0.18%
1,727,918
+120,300
+7% +$1.39M
DCO icon
145
Ducommun
DCO
$2.56B
$16.3M 0.18%
411,502
+12,100
+3% +$537K
DRVN icon
146
Driven Brands
DRVN
$2.47B
$16.3M 0.18%
583,265
-820
-0.1% -$25.2K
IIVI
147
DELISTED
Coherent Corp. 6.00% Series A Mandatory Convertible Preferred Stock
IIVI
$16.3M 0.18%
104,214
+21,581
+26% +$4.39M
WTM icon
148
White Mountains Insurance
WTM
$5.33B
$16.3M 0.18%
12,506
+2,040
+19% +$2.64M
TKR icon
149
Timken Company
TKR
$9.19B
$16.1M 0.18%
272,647
-39,821
-13% -$2.47M
HEI icon
150
HEICO Corp
HEI
$49.6B
$16M 0.18%
111,104
-20,000
-15% -$3M

Similar funds

Royce & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Royce & Associates held 997 positions worth $8.84B, down 9% from $9.71B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Royce & Associates withdrew a net $334M in Q3 2022, closing 68 positions and reducing 362 holdings. Its most notable exit was Avalara, Inc., an estimated $17.4M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Kyndryl worth $17.6M.

  • Royce & Associates's largest Q3 2022 buy was Kyndryl: 2,126,158 shares worth $17.6M.
  • Royce & Associates added most to Carter's in Q3 2022, an estimated $21.6M increase.
  • Royce & Associates's biggest Q3 2022 reduction was Meridian Bioscience Inc, cutting an estimated $48.8M.
  • Royce & Associates fully exited Avalara, Inc. in Q3 2022, selling an estimated $17.4M.
  • Royce & Associates's ten largest holdings make up 9.4% of its $8.84B portfolio in Q3 2022.
  • Royce & Associates opened 62 new positions and closed 68 in Q3 2022.
  • Royce & Associates's portfolio value fell 9% quarter-over-quarter to $8.84B.

Based on Royce & Associates's 13F filing for Q3 2022, filed 3 Nov 2022.